Symbols / PYPD
PYPD Chart
About
PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 77.37M |
| Enterprise Value | 67.23M | Income | -34.17M | Sales | — |
| Book/sh | 0.60 | Cash/sh | 0.71 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | -4.59 | PEG | — |
| P/S | — | P/B | 7.05 | P/C | — |
| EV/EBITDA | -2.15 | EV/Sales | — | Quick Ratio | 1.67 |
| Current Ratio | 1.97 | Debt/Eq | 25.48 | LT Debt/Eq | — |
| EPS (ttm) | -2.09 | EPS next Y | -0.93 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-13 | ROA | -86.71% |
| ROE | -3.66% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 18.20M |
| Shs Float | 11.16M | Short Float | 0.21% | Short Ratio | 0.33 |
| Short Interest | — | 52W High | 5.12 | 52W Low | 2.30 |
| Beta | 1.49 | Avg Volume | 76.47K | Volume | 57.67K |
| Target Price | $12.25 | Recom | Strong_buy | Prev Close | $4.24 |
| Price | $4.25 | Change | 0.24% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$12.25
Mean price target
2. Current target
$4.25
Latest analyst target
3. DCF / Fair value
$12.25
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$4.25
Low
$9.00
High
$14.00
Mean
$12.25
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-11 | reit | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-11-13 | main | Roth Capital | Buy → Buy | $9 |
| 2025-08-14 | main | Craig-Hallum | Buy → Buy | $13 |
| 2025-08-13 | reit | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-06-18 | main | Roth Capital | Buy → Buy | $9 |
| 2025-06-17 | main | JMP Securities | Market Outperform → Market Outperform | $14 |
| 2025-06-09 | main | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-06-05 | init | Roth Capital | — → Buy | $9 |
| 2025-04-14 | reit | HC Wainwright & Co. | Buy → Buy | $11 |
| 2024-12-26 | main | HC Wainwright & Co. | Buy → Buy | $11 |
| 2024-12-16 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-11-04 | init | Craig-Hallum | — → Buy | $10 |
| 2024-10-02 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-06-18 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-05-09 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2024-05-01 | reit | HC Wainwright & Co. | Buy → Buy | $14 |
| 2023-10-23 | main | Barclays | Equal-Weight → Equal-Weight | $10 |
| 2023-10-12 | init | HC Wainwright & Co. | — → Buy | $16 |
| 2022-09-07 | down | Barclays | Overweight → Equal-Weight | $3 |
- $PYPD ($PYPD) Releases Q4 2025 Earnings - Quiver Quantitative Wed, 11 Feb 2026 08
- When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo Finance Fri, 13 Feb 2026 08
- PolyPid (Nasdaq: PYPD) appoints Brooke Story, 25-year MedTech leader, as board chair - Stock Titan ue, 16 Dec 2025 08
- PolyPid (PYPD) Analyst Rating Reiteration by HC Wainwright | PYP - GuruFocus Wed, 11 Feb 2026 18
- Roth Capital Initiates Coverage of PolyPid (PYPD) with Buy Recommendation - Nasdaq hu, 05 Jun 2025 07
- Is PolyPid (NASDAQ:PYPD) A Risky Investment? - simplywall.st ue, 28 Oct 2025 07
- PolyPid stock rises after FDA supports NDA submission for D-PLEX100 By Investing.com - Investing.com South Africa Wed, 03 Dec 2025 08
- PolyPid (PYPD) Q4 2025 Earnings Call Transcript - The Globe and Mail Wed, 11 Feb 2026 08
- Preview: PolyPid's Earnings - Benzinga ue, 10 Feb 2026 20
- PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 - GlobeNewswire Wed, 28 Jan 2026 08
- Craig-Hallum Maintains PolyPid(PYPD.US) With Buy Rating, Announces Target Price $13 - 富途牛牛 Sat, 14 Feb 2026 23
- How Medallion Financial Corp. stock reacts to Fed rate cuts - Market Rally & AI Driven Stock Movement Reports - mfd.ru Fri, 20 Feb 2026 17
- PYPD Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 01
- PolyPid Earnings Call Flags Big 2026 Catalyst - TipRanks Wed, 11 Feb 2026 08
- PYPD - Finviz Fri, 10 Jul 2020 15
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.23 | 0.23 | 0.23 | 0.00 |
| NormalizedEBITDA | -26.41M | -21.05M | -37.17M | -41.53M |
| TotalUnusualItems | 234.00K | 532.00K | 44.00K | |
| TotalUnusualItemsExcludingGoodwill | 234.00K | 532.00K | 44.00K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -29.02M | -23.86M | -39.56M | -42.60M |
| ReconciledDepreciation | 1.62M | 1.82M | 1.72M | 1.12M |
| EBITDA | -26.41M | -21.05M | -37.17M | -41.48M |
| EBIT | -28.03M | -22.87M | -38.89M | -42.60M |
| NetInterestIncome | -951.00K | -929.00K | -540.00K | 500.00K |
| InterestExpense | 951.00K | 929.00K | 540.00K | 0.00 |
| InterestIncome | 548.00K | 267.00K | 468.00K | |
| NormalizedIncome | -29.02M | -23.86M | -39.56M | -42.65M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -29.02M | -23.86M | -39.56M | -42.60M |
| TotalExpenses | 28.03M | 22.87M | 38.89M | 43.15M |
| TotalOperatingIncomeAsReported | -28.03M | -22.87M | -38.89M | -43.15M |
| DilutedAverageShares | 5.91M | 1.42M | 647.56K | 624.05K |
| BasicAverageShares | 5.91M | 1.40M | 647.56K | 624.05K |
| DilutedEPS | -4.91 | -16.99 | -60.90 | -67.80 |
| BasicEPS | -4.91 | -16.99 | -60.90 | -67.80 |
| DilutedNIAvailtoComStockholders | -29.02M | -23.86M | -39.56M | -42.60M |
| NetIncomeCommonStockholders | -29.02M | -23.86M | -39.56M | -42.60M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| NetIncome | -29.02M | -23.86M | -39.56M | -42.60M |
| NetIncomeIncludingNoncontrollingInterests | -29.02M | -23.86M | -39.56M | -42.60M |
| NetIncomeContinuousOperations | -29.02M | -23.86M | -39.56M | -42.60M |
| TaxProvision | 42.00K | 69.00K | 129.00K | 0.00 |
| PretaxIncome | -28.98M | -23.80M | -39.43M | -42.60M |
| OtherIncomeExpense | 234.00K | 532.00K | 44.00K | |
| GainOnSaleOfSecurity | 234.00K | 532.00K | 44.00K | |
| NetNonOperatingInterestIncomeExpense | -951.00K | -929.00K | -540.00K | 500.00K |
| TotalOtherFinanceCost | 93.00K | 316.00K | -32.00K | |
| InterestExpenseNonOperating | 951.00K | 929.00K | 540.00K | 0.00 |
| InterestIncomeNonOperating | 548.00K | 267.00K | 468.00K | |
| OperatingIncome | -28.03M | -22.87M | -38.89M | -43.15M |
| OperatingExpense | 28.03M | 22.87M | 38.89M | 43.15M |
| ResearchAndDevelopment | 22.81M | 16.15M | 27.99M | 30.55M |
| SellingGeneralAndAdministration | 5.22M | 6.72M | 10.90M | 12.59M |
| SellingAndMarketingExpense | 945.00K | 1.20M | 2.89M | 2.98M |
| GeneralAndAdministrativeExpense | 4.27M | 5.52M | 8.01M | 9.61M |
| OtherGandA | 4.27M | 5.52M | 8.01M | 9.61M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 10.19M | 1.65M | 661.73K | 625.22K |
| ShareIssued | 10.19M | 1.65M | 661.73K | 625.22K |
| NetDebt | 5.07M | 3.05M | ||
| TotalDebt | 9.62M | 11.78M | 13.73M | 0.00 |
| TangibleBookValue | 7.68M | -2.10M | 5.83M | 35.96M |
| InvestedCapital | 15.11M | 8.29M | 17.43M | 35.96M |
| WorkingCapital | 3.89M | -1.22M | 5.64M | 26.73M |
| NetTangibleAssets | 7.68M | -2.10M | 5.83M | 35.96M |
| CapitalLeaseObligations | 2.20M | 1.40M | 2.13M | 0.00 |
| CommonStockEquity | 7.68M | -2.10M | 5.83M | 35.96M |
| TotalCapitalization | 8.32M | 4.28M | 13.40M | 35.96M |
| TotalEquityGrossMinorityInterest | 7.68M | -2.10M | 5.83M | 35.96M |
| StockholdersEquity | 7.68M | -2.10M | 5.83M | 35.96M |
| RetainedEarnings | -267.33M | -238.31M | -214.44M | -174.89M |
| AdditionalPaidInCapital | 275.01M | 236.21M | 220.27M | 210.85M |
| CapitalStock | 0.00 | 0.00 | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 17.54M | 17.47M | 20.14M | 8.28M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.86M | 10.18M | 11.59M | 199.00K |
| OtherNonCurrentLiabilities | 396.00K | 398.00K | 294.00K | 199.00K |
| NonCurrentDeferredLiabilities | 2.55M | 2.55M | 2.55M | 0.00 |
| NonCurrentDeferredRevenue | 2.55M | 2.55M | 2.55M | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 1.91M | 7.24M | 8.75M | 0.00 |
| LongTermCapitalLeaseObligation | 1.28M | 857.00K | 1.17M | 0.00 |
| LongTermDebt | 634.00K | 6.38M | 7.57M | |
| CurrentLiabilities | 12.68M | 7.29M | 8.55M | 8.08M |
| OtherCurrentLiabilities | 23.00K | 18.00K | 16.00K | |
| CurrentDeferredLiabilities | 0.00 | 269.00K | ||
| CurrentDeferredRevenue | 0.00 | 269.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 7.71M | 4.54M | 4.98M | |
| CurrentCapitalLeaseObligation | 919.00K | 540.00K | 959.00K | 0.00 |
| CurrentDebt | 6.79M | 4.00M | 4.02M | |
| OtherCurrentBorrowings | 6.79M | 4.00M | 4.02M | |
| PayablesAndAccruedExpenses | 4.95M | 2.73M | 3.55M | 7.81M |
| CurrentAccruedExpenses | 2.54M | 1.95M | 2.41M | 3.67M |
| Payables | 2.41M | 772.00K | 1.14M | 4.14M |
| OtherPayable | 16.00K | 5.00K | ||
| AccountsPayable | 2.41M | 772.00K | 1.14M | 4.14M |
| TotalAssets | 25.22M | 15.37M | 25.97M | 44.23M |
| TotalNonCurrentAssets | 8.65M | 9.30M | 11.78M | 9.42M |
| OtherNonCurrentAssets | 277.00K | 87.00K | 99.00K | 663.00K |
| NonCurrentPrepaidAssets | 0.00 | |||
| NetPPE | 8.37M | 9.22M | 11.68M | 8.76M |
| AccumulatedDepreciation | -9.42M | -7.80M | -5.97M | -4.25M |
| GrossPPE | 17.79M | 17.02M | 17.65M | 13.02M |
| Leases | 6.52M | 6.50M | 6.50M | 6.02M |
| OtherProperties | 10.46M | 9.72M | 10.36M | 6.25M |
| MachineryFurnitureEquipment | 803.00K | 793.00K | 786.00K | 744.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 16.57M | 6.07M | 14.19M | 34.81M |
| OtherCurrentAssets | 434.00K | 106.00K | 537.00K | 596.00K |
| RestrictedCash | 168.00K | 300.00K | 511.00K | 397.00K |
| PrepaidAssets | 330.00K | 352.00K | 552.00K | 1.50M |
| Receivables | 298.00K | 118.00K | ||
| OtherReceivables | 298.00K | 118.00K | ||
| CashCashEquivalentsAndShortTermInvestments | 15.64M | 5.31M | 12.59M | 32.20M |
| OtherShortTermInvestments | 0.00 | 4.04M | 22.38M | |
| CashAndCashEquivalents | 15.64M | 5.31M | 8.55M | 9.82M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -22.04M | -17.43M | -36.08M | -35.38M |
| RepaymentOfDebt | -3.32M | -2.62M | -402.00K | 0.00 |
| IssuanceOfDebt | 0.00 | 0.00 | 11.71M | 0.00 |
| IssuanceOfCapitalStock | 35.86M | 12.71M | 5.01M | 0.00 |
| CapitalExpenditure | -76.00K | -196.00K | -1.77M | -2.99M |
| InterestPaidSupplementalData | 950.00K | 1.04M | 734.00K | 0.00 |
| IncomeTaxPaidSupplementalData | 3.00K | 18.00K | 8.00K | 0.00 |
| EndCashPosition | 15.81M | 5.69M | 9.14M | 10.46M |
| BeginningCashPosition | 5.69M | 9.14M | 10.46M | 4.91M |
| ChangesInCash | 10.12M | -3.46M | -1.31M | 5.55M |
| FinancingCashFlow | 32.42M | 9.98M | 16.43M | 1.03M |
| CashFlowFromContinuingFinancingActivities | 32.42M | 9.98M | 16.43M | 1.03M |
| NetOtherFinancingCharges | -125.00K | -125.00K | ||
| ProceedsFromStockOptionExercised | 0.00 | 9.00K | 108.00K | 1.03M |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 35.86M | 12.71M | 5.01M | 0.00 |
| CommonStockIssuance | 35.86M | 12.71M | 5.01M | 0.00 |
| NetIssuancePaymentsOfDebt | -3.32M | -2.62M | 11.31M | 0.00 |
| NetLongTermDebtIssuance | -3.32M | -2.62M | 11.31M | 0.00 |
| LongTermDebtPayments | -3.32M | -2.62M | -402.00K | 0.00 |
| LongTermDebtIssuance | 0.00 | 0.00 | 11.71M | 0.00 |
| InvestingCashFlow | -330.00K | 3.80M | 16.57M | 36.90M |
| CashFlowFromContinuingInvestingActivities | -330.00K | 3.80M | 16.57M | 36.90M |
| NetInvestmentPurchaseAndSale | -254.00K | 4.00M | 18.34M | 39.89M |
| SaleOfInvestment | 21.10M | 22.60M | 25.34M | 47.89M |
| PurchaseOfInvestment | -21.35M | -18.60M | -7.00M | -8.00M |
| NetPPEPurchaseAndSale | -76.00K | -196.00K | -1.77M | -2.99M |
| PurchaseOfPPE | -76.00K | -196.00K | -1.77M | -2.99M |
| OperatingCashFlow | -21.96M | -17.24M | -34.32M | -32.39M |
| CashFlowFromContinuingOperatingActivities | -21.96M | -17.24M | -34.32M | -32.39M |
| ChangeInWorkingCapital | 1.92M | -110.00K | -1.08M | 4.35M |
| ChangeInOtherWorkingCapital | 2.55M | |||
| ChangeInOtherCurrentLiabilities | -723.00K | -494.00K | 2.13M | 0.00 |
| ChangeInOtherCurrentAssets | 824.00K | 593.00K | -2.43M | 0.00 |
| ChangeInPayablesAndAccruedExpense | 2.13M | -850.00K | -4.51M | 4.26M |
| ChangeInAccruedExpense | 493.00K | -481.00K | -1.42M | 2.04M |
| ChangeInPayable | 1.64M | -369.00K | -3.10M | 2.22M |
| ChangeInAccountPayable | 1.64M | -369.00K | -3.10M | 2.22M |
| ChangeInPrepaidAssets | -315.00K | 641.00K | 1.19M | 83.00K |
| OtherNonCashItems | 697.00K | 1.73M | 289.00K | |
| StockBasedCompensation | 2.82M | 3.39M | 4.31M | 4.75M |
| DepreciationAmortizationDepletion | 1.62M | 1.82M | 1.72M | 1.12M |
| DepreciationAndAmortization | 1.62M | 1.82M | 1.72M | 1.12M |
| Depreciation | 1.62M | 1.82M | 1.72M | 1.12M |
| OperatingGainsLosses | -201.00K | |||
| GainLossOnInvestmentSecurities | -201.00K | |||
| NetIncomeFromContinuingOperations | -29.02M | -23.86M | -39.56M | -42.60M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for PYPD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|